Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination of white mustard (Sinapis alba) and ginger (Zingiber officinale) is used in some experimental and traditional formulations, particularly for topical or transdermal applications targeting inflammatory conditions such as arthritis. The combination leverages the anti-inflammatory properties of both ingredients. Ginger contains bioactive compounds like gingerol, 4-hydroxy-3-methoxyphenylacetone, tetrahydrocurcumin, 10-gingerdione, and gingerdiol that may act through multiple anti-inflammatory pathways. White mustard oil is also known for its potential analgesic and counterirritant effects. Together, these ingredients are being investigated for synergistic benefits in pain relief and inflammation reduction when delivered via transdermal patches[1]. There is no evidence this specific combination has been approved as a pharmaceutical drug; it is primarily studied as a novel herbal or dietary supplement approach.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on white mustard + ginger.